Evidence map›Paper›PMID 31429405›Full record

ArticleeLife2019

Mucosal infection rewires TNFɑ signaling dynamics to skew susceptibility to recurrence.

Lu Yu, Valerie P O'Brien, Jonathan Livny, Denise Dorsey, Nirmalya Bandyopadhyay, Marco Colonna, Michael G Caparon, Elisha DO Roberson, Scott J Hultgren, Thomas J Hannan

Open access · goldAbstract read
In one paragraph

Article in eLife, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. More than an infection: the ecological puzzle of recurrent urinary tract infections.Frontiers in cellular and infection microbiology · 2026
    Review
  7. Article
  8. CAUTIon - not all UTIs are the same.Nature reviews. Urology · 2025
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. The immune mechanisms of the urinary tract against infections.Frontiers in cellular and infection microbiology · 2025
    Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Lu Yu *Department of Molecular Microbiology and Center for Women's Infectious Disease Research, Washington University School of Medicine, St Louis, United States.ORCID 0000-0002-2361-2347
Valerie P O'Brien *Department of Molecular Microbiology and Center for Women's Infectious Disease Research, Washington University School of Medicine, St Louis, United States.ORCID 0000-0003-0502-2690
Jonathan LivnyThe Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, United States.
Denise DorseyDepartment of Molecular Microbiology and Center for Women's Infectious Disease Research, Washington University School of Medicine, St Louis, United States.
Nirmalya BandyopadhyayThe Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, United States.
Marco ColonnaDepartment of Pathology and Immunology, Washington University School of Medicine, St Louis, United States.
Michael G CaparonDepartment of Molecular Microbiology and Center for Women's Infectious Disease Research, Washington University School of Medicine, St Louis, United States.
Elisha DO RobersonDepartment of Medicine, Division of Rheumatology, Washington University School of Medicine, St Louis, United States.ORCID 0000-0001-5921-2399
Scott J HultgrenDepartment of Molecular Microbiology and Center for Women's Infectious Disease Research, Washington University School of Medicine, St Louis, United States.ORCID 0000-0001-8785-564X
Thomas J HannanDepartment of Molecular Microbiology and Center for Women's Infectious Disease Research, Washington University School of Medicine, St Louis, United States.ORCID 0000-0003-0498-8231
Washington University in St. Louis · USBroad Institute · US

Funding

Viral Genomics: evolution, spread, and host interactionsU19AI110818 · NIAID · BROAD INSTITUTE, INC. · PI EARL, ASHLEE MIRIAM · 2014 to 2024
$66.5M
pan-Genome of E.coli in the bladder and gut of women with recurrent UTIP50DK064540 · NIDDK · WASHINGTON UNIVERSITY · PI HULTGREN, SCOTT J. · 2002 to 2017
$17.9M
Mucosal Immune Defense Mechanisms of the Urinary BladderU01AI095542 · NIAID · WASHINGTON UNIVERSITY · PI COLONNA, MARCO, HULTGREN, SCOTT J. · 2011 to 2020
$9.8M
Human MAIT celis in airway mucosal immune responses to intracellular infectionsU01AI095776 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI LEWINSOHN, DAVID M. · 2011 to 2015
$8.9M
MOLECULAR BASIS OF E. COLI ADHESINS IN BLADDER DISORDERSR01DK051406 · NIDDK · WASHINGTON UNIVERSITY · PI SCOTT J. HULTGREN · 1997 to 2026
$8.8M
Washington University Rheumatic DiseasesResearch Resource-based CenterP30AR073752 · NIAMS · WASHINGTON UNIVERSITY · PI Megan Anne Cooper · 2018 to 2026
$7.6M
Mucosal Immune Checkpoints in Chronic Bacterial CystitisK08AI083746 · NIAID · WASHINGTON UNIVERSITY · PI HANNAN, THOMAS JOSEPH · 2009 to 2011
$356k
National Institute of Allergy and Infectious Diseases U01 AI95542National Science Foundation Graduate Research Fellowship #DGE-114395NIAID NIH HHS K08 AI083746NIAID NIH HHS U01 AI095542NIAID NIH HHS U01 AI095776NIAID NIH HHS U19 AI110818NIAMS NIH HHS P30 AR073752NIDDK NIH HHS P50 DK064540NIDDK NIH HHS R01 DK051406NIDDK NIH HHS R01 DK51406NIH Office of the Director P50 DK64540
6 · The paper itself

Abstract

A mucosal infectious disease episode can render the host either more or less susceptible to recurrent infection, but the specific mechanisms that tip the balance remain unclear. We investigated this question in a mouse model of recurrent urinary tract infection and found that a prior bladder infection resulted in an earlier onset of tumor necrosis factor-alpha (TNFɑ)-mediated bladder inflammation upon subsequent bacterial challenge, relative to age-matched naive mice. However, the duration of TNFɑ signaling activation differed according to whether the first infection was chronic (Sensitized) or self-limiting (Resolved). TNFɑ depletion studies revealed that transient early-phase TNFɑ signaling in Resolved mice promoted clearance of bladder-colonizing bacteria via rapid recruitment of neutrophils and subsequent exfoliation of infected bladder cells. In contrast, sustained TNFɑ signaling in Sensitized mice prolonged damaging inflammation, worsening infection. This work reveals how TNFɑ signaling dynamics can be rewired by a prior infection to shape diverse susceptibilities to future mucosal infections.

Indexed as

Immunity, MucosalSignal TransductionAnimalsDisease Models, AnimalImmunologic FactorsMiceRecurrenceSecondary PreventionTumor Necrosis Factor-alphaUrinary Tract InfectionsImmunologic FactorsTumor Necrosis Factor-alphaE. coliimmunologyinfectious diseaseinflammationmicrobiologymousemucosal infectionmucosal remodelingrecurrent infectiontumor necrosis factor alphaurinary tract infectionuropathogenic E. coli

Identifiers

PMID31429405
PMCPMC6701943
OpenAlexW2965443321

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.